x
|
QUARTERLY REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Large Accelerated Filer þ | Accelerated Filer o |
Non-Accelerated Filer o | Smaller Reporting Company o |
(Do not check if a smaller reporting company.) |
ASHLAND
INC. AND CONSOLIDATED SUBSIDIARIES
|
|||||||||
STATEMENTS
OF CONSOLIDATED INCOME
|
|||||||||
Three
months ended
|
|||||||||
December
31
|
|||||||||
(In
millions except per share data - unaudited)
|
2009
|
2008
|
(d) | ||||||
SALES
|
$ | 2,020 | $ | 1,966 | |||||
COSTS
AND EXPENSES
|
|||||||||
Cost of sales
(a)
|
1,534 | 1,641 | |||||||
Selling, general and
administrative expenses (a)
|
334 | 317 | |||||||
Research and development expenses (b) | 20 | 27 | |||||||
1,888 | 1,985 | ||||||||
EQUITY
AND OTHER INCOME
|
14 | 12 | |||||||
OPERATING
INCOME (LOSS)
|
146 | (7 | ) | ||||||
Net
interest and other financing expense
|
(41 | ) | (28 | ) | |||||
Net
gain on divestitures
|
- | 1 | |||||||
Other expenses (c)
|
- | (86 | ) | ||||||
INCOME
(LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
|
105 | (120 | ) | ||||||
Income
tax expense (benefit) - Note J
|
29 | (1 | ) | ||||||
INCOME
(LOSS) FROM CONTINUING OPERATIONS
|
76 | (119 | ) | ||||||
Income
from discontinued operations (net of income taxes) - Note
E
|
10 | - | |||||||
NET
INCOME (LOSS)
|
$ | 86 | $ | (119 | ) | ||||
BASIC
EARNINGS PER SHARE - Note K
|
|||||||||
Income
(loss) from continuing operations
|
$ | .99 | $ | (1.73 | ) | ||||
Income
from discontinued operations
|
.14 | - | |||||||
Net
income (loss)
|
$ | 1.13 | $ | (1.73 | ) | ||||
DILUTED
EARNINGS PER SHARE - Note K
|
|||||||||
Income
(loss) from continuing operations
|
$ | .97 | $ | (1.73 | ) | ||||
Income
from discontinued operations
|
.13 | - | |||||||
Net
income (loss)
|
$ | 1.10 | $ | (1.73 | ) | ||||
DIVIDENDS
PAID PER COMMON SHARE
|
$ | .075 | $ | .075 | |||||
(a)
|
The
three months ended December 31, 2009 includes $2 million within the
selling, general and administrative expenses caption for restructuring
charges. The three months ended December 31, 2008 includes a $26
million severance charge within the selling, general and administrative
expense caption for the ongoing integration and reorganization from the
Hercules acquisition and other cost reduction programs and a $21 million
charge recorded within the cost of sales caption for a one-time fair value
assessment of Hercules inventory as of the date of the
transaction.
|
(b)
|
The
three months ended December 31, 2008 includes a $10 million charge related
to the valuation of the ongoing research and development projects at
Hercules as of the merger date. In accordance with applicable GAAP
and SEC accounting regulations, these purchased in-process research and
development costs were expensed upon
acquisition.
|
(c)
|
The
three months ended December 31, 2008 includes a $54 million loss on
currency swaps related to the Hercules acquisition and a $32 million loss
on auction rate securities.
|
(d)
|
Results
from the acquired operations of Hercules are included herein as of
November 14, 2008 through December 31,
2008.
|
ASHLAND
INC. AND CONSOLIDATED SUBSIDIARIES
|
||||||||||||
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
||||||||||||
December
31
|
September
30
|
December
31
|
||||||||||
(In
millions - unaudited)
|
2009
|
2009
|
2008
|
|||||||||
ASSETS
|
||||||||||||
CURRENT
ASSETS
|
||||||||||||
Cash
and cash equivalents
|
$ | 406 | $ | 352 | $ | 222 | ||||||
Accounts
receivable (a)
|
1,289 | 1,392 | 1,499 | |||||||||
Inventories
- Note H
|
593 | 527 | 688 | |||||||||
Deferred
income taxes
|
101 | 115 | 103 | |||||||||
Other
current assets
|
32 | 40 | 121 | |||||||||
Current
assets held for sale - Note C
|
46 | 41 | 88 | |||||||||
2,467 | 2,467 | 2,721 | ||||||||||
NONCURRENT
ASSETS
|
||||||||||||
Auction
rate securities - Note F
|
126 | 170 | 225 | |||||||||
Goodwill
- Note I
|
2,213 | 2,220 | 2,100 | |||||||||
Intangibles
- Note I
|
1,182 | 1,204 | 1,328 | |||||||||
Asbestos
insurance receivable (noncurrent portion) - Note O
|
484 | 510 | 447 | |||||||||
Deferred income taxes | 100 | 161 | - | |||||||||
Other
noncurrent assets
|
585 | 596 | 639 | |||||||||
Noncurrent
assets held for sale - Note C
|
60 | 61 | 91 | |||||||||
4,750 | 4,922 | 4,830 | ||||||||||
PROPERTY,
PLANT AND EQUIPMENT
|
||||||||||||
Cost
|
3,451 | 3,449 | 3,429 | |||||||||
Accumulated
depreciation and amortization
|
(1,438 | ) | (1,391 | ) | (1,238 | ) | ||||||
2,013 | 2,058 | 2,191 | ||||||||||
TOTAL
ASSETS
|
$ | 9,230 | $ | 9,447 | $ | 9,742 | ||||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||||||
CURRENT
LIABILITIES
|
||||||||||||
Short-term
debt - Note G
|
$ | 28 | $ | 23 | $ | 246 | ||||||
Current
portion of long-term debt - Note G
|
50 | 53 | 94 | |||||||||
Trade and other payables | 834 | 944 | 871 | |||||||||
Accrued
expenses and other liabilities
|
439 | 541 | 505 | |||||||||
Current
liabilities held for sale - Note C
|
6 | 5 | 23 | |||||||||
1,357 | 1,566 | 1,739 | ||||||||||
NONCURRENT
LIABILITIES
|
||||||||||||
Long-term
debt (noncurrent portion) - Note G
|
1,516 | 1,537 | 2,128 | |||||||||
Employee
benefit obligations - Note L
|
1,118 | 1,214 | 663 | |||||||||
Asbestos
litigation reserve (noncurrent portion) - Note O
|
906 | 956 | 807 | |||||||||
Deferred
income taxes
|
- | - | 236 | |||||||||
Other
noncurrent liabilities
|
579 | 590 | 569 | |||||||||
4,119 | 4,297 | 4,403 | ||||||||||
STOCKHOLDERS’
EQUITY
|
3,754 | 3,584 | 3,600 | |||||||||
TOTAL
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$ | 9,230 | $ | 9,447 | $ | 9,742 | ||||||
(a)
|
Accounts
receivable includes an allowance for doubtful accounts of $38 million and
$31 million at December 31, 2009 and 2008, respectively, and $38 million
at September 30, 2009.
|
ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES |
STATEMENTS OF CONSOLIDATED STOCKHOLDERS’ EQUITY |
Accumulated | ||||||||||||||||||||
other | ||||||||||||||||||||
Common | Paid-in | Retained | comprehensive | |||||||||||||||||
(In millions - unaudited) | stock | capital | earnings | income (loss) | (a) | Total | ||||||||||||||
BALANCE
AT SEPTEMBER 30, 2008
|
$ | 1 | $ | 33 | $ | 3,138 | $ | 30 | $ | 3,202 | ||||||||||
Total
comprehensive (loss) income (b)
|
(119 | ) | 59 | (60 | ) | |||||||||||||||
Regular
dividend, $.075 per common share
|
(6 | ) | (6 | ) | ||||||||||||||||
Issuance of common shares - Note M | 450 | 450 | ||||||||||||||||||
Issued 169,308 common shares under stock | ||||||||||||||||||||
incentive and other plans (c)
|
13 | 13 | ||||||||||||||||||
Other | 1 | 1 | ||||||||||||||||||
BALANCE
AT DECEMBER 31, 2008
|
$ | 1 | $ | 497 | $ | 3,013 | $ | 89 | $ | 3,600 | ||||||||||
BALANCE
AT SEPTEMBER 30, 2009
|
$ | 1 | $ | 521 | $ | 3,185 | $ | (123 | ) | $ | 3,584 | |||||||||
Total
comprehensive (loss) income (b)
|
86 | (19 | ) | 67 | ||||||||||||||||
Regular
dividends, $.075 per common share
|
(6 | ) | (6 | ) | ||||||||||||||||
Issuance
of common shares (d) - Note M
|
100 | 100 | ||||||||||||||||||
Issued 224,677
common shares under stock
|
||||||||||||||||||||
incentive and other plans
|
9 | 9 | ||||||||||||||||||
BALANCE
AT DECEMBER 31, 2009
|
$ | 1 | $ | 630 | $ | 3,265 | $ | (142 | ) | $ | 3,754 | |||||||||
(a)
|
At
December 31, 2009 and 2008, the after-tax accumulated other comprehensive
income (loss) of ($142) million for 2009 and $89 million for 2008 was
comprised of pension and postretirement obligations of $462 million for
2009 and $106 million for 2008 and net unrealized translation gains of
$320 million for 2009 and $195 million for
2008.
|
(b)
|
Reconciliations
of net income (loss) to total comprehensive income (loss)
follow.
|
|
||||||||||||||||||||||
|
Three months ended | |||||||||||||||||||||
December
31
|
||||||||||||||||||||||
(In
millions)
|
2009 | 2008 | ||||||||||||||||||||
Net
income (loss)
|
$ | 86 | $ | (119 | ) | |||||||||||||||||
Pension
and postretirement obligation adjustments, net of tax
|
- | 1 | ||||||||||||||||||||
Unrealized
translation (loss) gain, net of tax
|
(19 | ) | 38 | |||||||||||||||||||
Unrealized losses
on investment securities, net of tax
|
- | 20 | ||||||||||||||||||||
Total
comprehensive income (loss)
|
$ | 67 | $ | (60 | ) | |||||||||||||||||
(c)
|
Includes
$10 million from fair value of Hercules stock options converted into stock
options for Ashland shares.
|
(d)
|
Relates
to the November 2009 voluntary pension plan contribution of approximately
3.0 million shares of Ashland Common
Stock.
|
|
||||||||||||||||||||||
|
ASHLAND
INC. AND CONSOLIDATED SUBSIDIARIES
|
||||||||
STATEMENTS
OF CONDENSED CONSOLIDATED CASH FLOWS
|
||||||||
Three
months ended
|
||||||||
December
31
|
||||||||
(In
millions - unaudited)
|
2009
|
2008
|
||||||
CASH
FLOWS PROVIDED BY OPERATING ACTIVITIES FROM CONTINUING
OPERATIONS
|
||||||||
Net income (loss) | $ | 86 | $ | (119 | ) | |||
Income
from discontinued operations (net of income taxes)
|
(10 | ) | - | |||||
Adjustments
to reconcile income (loss) from continuing operations to cash flows from
operating activities
|
||||||||
Depreciation
and amortization
|
80 | 62 | ||||||
Debt issuance cost amortization | 6 | 6 | ||||||
Purchased
in-process research and development amortization
|
- | 10 | ||||||
Deferred
income taxes
|
26 | 13 | ||||||
Equity
income from affiliates
|
(6 | ) | (5 | ) | ||||
Distributions
from equity affiliates
|
5 | 2 | ||||||
Gain
from sale of property and equipment
|
(2 | ) | - | |||||
Stock
based compensation expense
|
4 | 2 | ||||||
Stock contributions to qualified savings plans | 9 | - | ||||||
Net
gain on divestitures
|
- | (1 | ) | |||||
Inventory
fair value adjustment related to Hercules acquisition
|
- | 21 | ||||||
Loss
on currency swaps related to Hercules acquisition
|
- | 54 | ||||||
Loss
on auction rate securities
|
- | 32 | ||||||
Change
in operating assets and liabilities (a)
|
(163 | ) | (3 | ) | ||||
35 | 74 | |||||||
CASH
FLOWS PROVIDED (USED) BY INVESTING ACTIVITIES FROM CONTINUING
OPERATIONS
|
||||||||
Additions
to property, plant and equipment
|
(21 | ) | (38 | ) | ||||
Proceeds
from disposal of property, plant and equipment
|
3 | 2 | ||||||
Purchase
of operations - net of cash acquired
|
- | (2,082 | ) | |||||
Proceeds
from sale of operations
|
- | 7 | ||||||
Settlement
of currency swaps related to Hercules acquisition
|
- | (95 | ) | |||||
Proceeds
from sales and maturities of available-for-sale securities
|
44 | 18 | ||||||
26 | (2,188 | ) | ||||||
CASH
FLOWS PROVIDED (USED) BY FINANCING ACTIVITIES FROM CONTINUING
OPERATIONS
|
||||||||
Proceeds
from issuance of long-term debt
|
- | 2,000 | ||||||
Repayment
of long-term debt
|
(25 | ) | (601 | ) | ||||
Proceeds
from/repayments of issuance of short-term debt
|
6 | 205 | ||||||
Debt
issuance/modification costs
|
- | (138 | ) | |||||
Cash
dividends paid
|
(6 | ) | (6 | ) | ||||
Proceeds
from exercise of stock options
|
1 | - | ||||||
(24 | ) | 1,460 | ||||||
CASH
PROVIDED (USED) BY CONTINUING OPERATIONS
|
37 | (654 | ) | |||||
Cash
used by discontinued operations
|
||||||||
Operating
cash flows
|
13 | 5 | ||||||
Effect
of currency exchange rate changes on cash and cash
equivalents
|
4 | (15 | ) | |||||
INCREASE
(DECREASE) IN CASH AND CASH EQUIVALENTS
|
54 | (664 | ) | |||||
CASH
AND CASH EQUIVALENTS - BEGINNING OF YEAR
|
352 | 886 | ||||||
CASH
AND CASH EQUIVALENTS - END OF PERIOD
|
$ | 406 | $ | 222 | ||||
Purchase
price allocation (in millions)
|
At
November 13
2008
|
||||
Assets: |
|
|
|
||
Cash | $ | 54 | |||
Accounts
receivable
|
355 | ||||
Inventory | 261 | ||||
Other current assets | 57 | ||||
Intangible assets | 1,116 | ||||
Goodwill | 1,815 | ||||
Asbestos receivable | 97 | ||||
Property, plant and equipment | 1,059 | ||||
Purchased in-process research and development | 10 | ||||
Other noncurrent assets | 164 | ||||
Liabilities: | |||||
Accounts payable | (232 | ) | |||
Accrued expenses | (217 | ) | |||
Debt |
(798
|
)
|
|||
Pension and other postretirement obligations |
(316
|
)
|
|||
Environmental | (106 | ) | |||
Asbestos |
(459
|
)
|
|||
Deferred tax - net |
(144
|
)
|
|||
Other noncurrent liabilities |
(122
|
)
|
|||
Total purchase price |
$
|
2,594
|
(In
millions)
|
||||||
Functional
Ingredients
|
Corebond
|
$ | 2 | |||
Water
Technologies
|
Biofilm
Sensor
|
$ | 2 | |||
Water
Technologies
|
Surface
Dry Strength
|
$ | 2 | |||
Functional
Ingredients / Water Technologies
|
Other
|
$ | 4 | |||
Life
|
|||||||||
Intangible
asset type (in millions)
|
Value
|
(years)
|
|||||||
Customer
relationships - Functional Ingredients
|
$ | 289 | 10 - 24 | ||||||
Customer
relationships - Water Technologies
|
240 | 12 | |||||||
Developed
technology - Functional Ingredients
|
217 | 15 | |||||||
Developed
technology - Water Technologies
|
60 | 5 - 20 | |||||||
Product
trade names - Functional Ingredients
|
32 | 20 | |||||||
Product trade names - Functional Ingredients | 104 | Indefinite | |||||||
Product
trade names - Water Technologies
|
151 |
Indefinite
|
|||||||
Other
|
23 |
36
- 47
|
|||||||
Total
|
$ | 1,116 |
December 31 |
September
30
|
December 31 | ||||||||||||
(In
millions - unaudited)
|
2009
|
2009
|
2008
|
|||||||||||
Accounts
receivable
|
$ | 13 | $ | 13 | $ | 40 | ||||||||
Inventories
|
33 | 28 | 48 | |||||||||||
Current
Assets
|
$ | 46 | $ | 41 | $ | 88 | ||||||||
Property,
plant and equipment, net
|
$ | 38 | $ | 39 | $ | 43 | ||||||||
Goodwill and intangible assets | - | - | 15 | |||||||||||
Other noncurrent assets | - | - | 6 | |||||||||||
Noncurrent assets | $ | 38 | $ | 39 | $ | 64 | ||||||||
Trade payables | $ | 6 | $ | 5 | $ | 22 | ||||||||
Accrued
expenses and other liabilities
|
- | - | 1 | |||||||||||
Current
liabilities
|
$ | 6 | $ | 5 | $ | 23 |
(In millions)
|
Severance
|
|
|||
Balance as of September 30, 2008 | $ | 7 | |||
Restructuring reserve | 42 | ||||
Utilization (cash paid or otherwise settled) | (1 | ) | |||
Balance at December 31, 2008 | $ | 48 | |||
Balance as of September 30, 2009 | $ | 38 | |||
Restructuring reserve | 2 | ||||
Utilization (cash paid or otherwise settled) | (9 | ) | |||
Balance at December 31, 2009 | $ | 31 |
|
Three months ended | |||||||||||||||||||||
December
31
|
||||||||||||||||||||||
(In
millions)
|
2009 | 2008 | ||||||||||||||||||||
Income from discontinued operations (net of tax) | ||||||||||||||||||||||
Asbestos-related
litigation reserves and receivables
|
$ | 9 | $ | - | ||||||||||||||||||
Income on disposal of discontinued operations (net of tax) | ||||||||||||||||||||||
APAC | 1 | - | ||||||||||||||||||||
Total income from discontinued operations (net of tax) | $ | 10 | $ | - | ||||||||||||||||||
Quoted prices | ||||||||||||||||||||||
in
active
|
Significant
|
|||||||||||||||||||||
markets
for
|
other
|
Significant
|
||||||||||||||||||||
|
Total |
identical
|
observable
|
unobservable
|
||||||||||||||||||
Carrying
|
fair |
assets
|
inputs
|
inputs
|
||||||||||||||||||
(In
millions)
|
value
|
value |
Level
1
|
Level
2
|
Level
3
|
|||||||||||||||||
Assets
|
||||||||||||||||||||||
Cash
and cash equivalents
|
$ | 406 | $ | 406 | $ | 406 | $ | - | $ | - | ||||||||||||
Auction
rate securities
|
126 | 126 | - | - | 126 | |||||||||||||||||
Deferred compensation investments
(a)
|
173 | 173 | 67 | 106 | - | |||||||||||||||||
Investments
(a)
|
3 | 3 | 3 | - | - | |||||||||||||||||
Total
assets at fair value
|
$ | 708 | $ | 708 | $ | 476 | $ | 106 | $ | 126 | ||||||||||||
(a) |
Included
in other noncurrent assets in the Condensed Consolidated Balance
Sheet.
|
(In
millions)
|
Level
3
|
|||||
Balance
as of October 1, 2009 (par value)
|
$ | 170 | ||||
Sales
of auction rate securities
|
(44 | ) | ||||
Balance
as of December 31, 2009
|
$ | 126 | ||||
December
31
|
September
30
|
December
31
|
||||||||||||
(In
millions)
|
2009
|
2009
|
2008
|
|||||||||||
Term loan A, due 2013
(a)
|
$ | 207 | $ | 219 | $ | 400 | ||||||||
Term loan B, due 2014
(a)
|
536 | 542 | 850 | |||||||||||
6.60% notes, due 2027
(b)
|
12 | 12 | 12 | |||||||||||
9.0%
Bridge loan, due 2009
|
- | - | 750 | |||||||||||
Accounts
receivable securitization
|
- | - | 200 | |||||||||||
9.125%
notes, due 2017
|
628 | 628 | - | |||||||||||
Medium-term
notes, due 2013-2019, interest at a weighted-
|
||||||||||||||
average
rate of 8.4% at December 31, 2009 (7.7% to 9.4%)
|
21 | 21 | 21 | |||||||||||
8.80%
debentures, due 2012
|
20 | 20 | 20 | |||||||||||
6.86%
medium-term notes, Series H, due 2009
|
- | - | 17 | |||||||||||
Hercules Tianpu - term notes, due
through 2011 (b)
|
12 | 19 | 44 | |||||||||||
6.50% junior subordinated notes,
due 2029 (b)
|
125 | 125 | 124 | |||||||||||
International
revolver agreements
|
28 | 22 | 18 | |||||||||||
Other
|
5 | 5 | 12 | |||||||||||
Total
debt
|
1,594 | 1,613 | 2,468 | |||||||||||
Short-term
debt
|
(28 | ) | (23 | ) | (246 | ) | ||||||||
Current
portion of long-term debt
|
(50 | ) | (53 | ) | (94 | ) | ||||||||
Long-term
debt (less current portion)
|
$ | 1,516 | $ | 1,537 | $ | 2,128 | ||||||||
(a) Senior credit facilities. | ||||||||||||||
(b) Hercules retained instruments. |
December
31
|
September
30
|
December
31
|
||||||||||||
(In
millions)
|
2009
|
2009
|
2008
|
|||||||||||
Finished
products
|
$ | 609 | $ | 540 | $ | 724 | ||||||||
Raw
materials, supplies and work in process
|
112 | 112 | 150 | |||||||||||
LIFO
carrying values
|
(128 | ) | (125 | ) | (186 | ) | ||||||||
$ | 593 | $ | 527 | $ | 688 | |||||||||
Functional
|
Water
|
Performance
|
Consumer
|
|||||||||||||||||||||||
(In
millions)
|
Ingredients
|
Technologies
|
Materials
|
(a)
|
Markets
|
Distribution
|
Total
|
|||||||||||||||||||
Balance
at September 30, 2009
|
$ | 1,106 | $ | 626 | $ | 293 | $ | 115 | $ | 80 | $ | 2,220 | ||||||||||||||
Acquisitions
|
6 | 3 | - | - | - | 9 | ||||||||||||||||||||
Currency
translation adjustment
|
(13 | ) | (3 | ) | - | - | - | (16 | ) | |||||||||||||||||
Balance
at December 31, 2009
|
$ | 1,099 | $ | 626 | $ | 293 | $ | 115 | $ | 80 | $ | 2,213 | ||||||||||||||
(a) |
Goodwill
consisted of $51 million and $242 million, respectively, for the Castings
Solutions and Composite Polymers/Specialty Polymers and Adhesives
reporting units.
|
Functional
|
Water
|
Performance
|
Consumer
|
|||||||||||||||||||||||
(In
millions)
|
Ingredients
|
Technologies
|
(a) |
Materials
|
(b)
|
Markets
|
Distribution
|
Total
|
||||||||||||||||||
Balance
at September 30, 2008
|
$ | - | $ | 56 | $ | 196 | $ | 30 | $ | 1 | $ | 283 | ||||||||||||||
Acquisitions | 981 | 490 | 97 | 85 | 79 | 1,732 | ||||||||||||||||||||
Currency
translation adjustment
|
64 | 24 | (3 | ) | - | - | 85 | |||||||||||||||||||
Balance
at December 31, 2008
|
$ | 1,045 | $ | 570 | $ | 290 | $ | 115 | $ | 80 | $ | 2,100 | ||||||||||||||
(a)
|
Excludes
goodwill of $15 million as of December 31, 2008 associated with the Drew
Marine sale during 2009 that has been classified within assets held for
sale.
|
(b)
|
Goodwill
consisted of $51 million and $239 million, respectively, for the Castings
Solutions and Composite Polymers/Specialty Polymers and Adhesives
reporting units.
|
December
31, 2009
|
||||||||||||||
Gross
|
Net
|
|||||||||||||
carrying
|
Accumulated
|
carrying
|
||||||||||||
(In
millions)
|
amount
|
amortization
|
amount
|
|||||||||||
Trademarks
and trade names
|
$ | 353 | $ | (25 | ) | $ | 328 | |||||||
Intellectual
property
|
331 | (47 | ) | 284 | ||||||||||
Customer
relationships
|
581 | (50 | ) | 531 | ||||||||||
Other
intangibles
|
63 | (24 | ) | 39 | ||||||||||
Total
intangible assets
|
$ | 1,328 | $ | (146 | ) | $ | 1,182 | |||||||
September
30, 2009
|
||||||||||||||
Gross
|
Net
|
|||||||||||||
carrying
|
Accumulated
|
carrying
|
||||||||||||
(In
millions)
|
amount
|
amortization
|
amount
|
|||||||||||
Trademarks
and trade names
|
$ | 353 | $ | (24 | ) | $ | 329 | |||||||
Intellectual
property
|
331 | (41 | ) | 290 | ||||||||||
Customer
relationships
|
586 | (40 | ) | 546 | ||||||||||
Other
intangibles
|
63 | (24 | ) | 39 | ||||||||||
Total
intangible assets
|
$ | 1,333 | $ | (129 | ) | $ | 1,204 | |||||||
|
December
31, 2008
|
||||||||||||||
Gross
|
Net
|
|||||||||||||
carrying
|
Accumulated
|
carrying
|
||||||||||||
(In
millions)
|
amount
|
amortization
|
amount
|
|||||||||||
Trademarks
and trade names
|
$ | 367 | $ | (22 | ) | $ | 345 | |||||||
Intellectual
property
|
343 | (24 | ) | 319 | ||||||||||
Customer
relationships
|
655 | (10 | ) | 645 | ||||||||||
Other
intangibles
|
38 | (19 | ) | 19 | ||||||||||
Total
intangible assets
|
$ | 1,403 | $ | (75 | ) | $ | 1,328 |
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions)
|
2009
|
2008
|
||||||||
Income
(loss) from continuing operations before income taxes
|
$ | 105 | $ | (120 | ) | |||||
Income
tax expense (benefit) computed at U.S. Federal statutory rates
(35%)
|
$ | 37 | $ | (42 | ) | |||||
Increase
(decrease) in amount computed resulting from:
|
||||||||||
Resolution,
evaluation and re-evaluation of tax positions
|
(6 | ) | 9 | |||||||
Adjustment
of statutory rates for projected annual income
|
(3 | ) | 3 | |||||||
Nondeductible
life insurance loss
|
(1 | ) | 5 | |||||||
Nondeductible
in-process research and development costs
|
- | 3 | ||||||||
APB 23 repatriated earnings
(a)
|
- | 14 | ||||||||
Auction
rate securities valuation allowance
|
- | 10 | ||||||||
Research
and development tax credits
|
- | (3 | ) | |||||||
Other
|
2 | - | ||||||||
Income
tax expense (benefit)
|
$ | 29 | $ | (1 | ) | |||||
(a)
|
Represents
repatriation of historical earnings of certain foreign
subsidiaries.
|
(In
millions)
|
||||||
Balance
at October 1, 2009
|
$ | 125 | ||||
Increases
related to positions taken on items from prior years
|
7 | |||||
Decreases
related to positions taken on items from prior years
|
(5 | ) | ||||
Increases
related to positions taken in the current year
|
1 | |||||
Lapse
of statute of limitations
|
(3 | ) | ||||
Settlement
of uncertain tax positions with tax authorities
|
(1 | ) | ||||
Balance
at December 31, 2009
|
$ | 124 |
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions except per share data)
|
2009
|
2008
|
||||||||
Numerator
|
||||||||||
Numerator
for basic and diluted EPS – Income (loss) from continuing
operations
|
$ | 76 | $ | (119 | ) | |||||
Denominator
|
||||||||||
Denominator
for basic EPS – Weighted-average common shares
outstanding
|
77 | 69 | ||||||||
Share
based awards convertible to common shares
|
1 | - | ||||||||
Denominator
for diluted EPS – Adjusted weighted-average shares and
assumed
|
||||||||||
conversions
|
78 | 69 | ||||||||
EPS
from continuing operations
|
||||||||||
Basic
|
$ | .99 | $ | (1.73 | ) | |||||
Diluted
|
$ | .97 | $ | (1.73 | ) | |||||
Other
postretirement
|
||||||||||||||||||
Pension
benefits
|
benefits
|
|||||||||||||||||
(In
millions)
|
2009
|
2008
|
2009
|
2008
|
||||||||||||||
Three
months ended December 31
|
||||||||||||||||||
Service
cost
|
$ | 13 | $ | 10 | $ | 1 | $ | 1 | ||||||||||
Interest
cost
|
51 | 44 | 5 | 5 | ||||||||||||||
Expected
return on plan assets
|
(54 | ) | (39 | ) | - | - | ||||||||||||
Amortization
of prior service credit
|
- | - | - | (1 | ) | |||||||||||||
Amortization
of net actuarial loss (gain)
|
13 | 4 | (1 | ) | (1 | ) | ||||||||||||
$ | 23 | $ | 19 | $ | 5 | $ | 4 | |||||||||||
Three
months ended
|
||||||||||||||||||||||
December
31
|
Years
ended September 30
|
|||||||||||||||||||||
(In
thousands)
|
2009
|
2008
|
2009
|
2008
|
2007
|
|||||||||||||||||
Open
claims - beginning of period
|
100 | 115 | 115 | 134 | 162 | |||||||||||||||||
New
claims filed
|
1 | 1 | 2 | 4 | 4 | |||||||||||||||||
Claims
settled
|
(1 | ) | (1 | ) | (1 | ) | (2 | ) | (2 | ) | ||||||||||||
Claims
dismissed
|
(8 | ) | (6 | ) | (16 | ) | (21 | ) | (30 | ) | ||||||||||||
Open
claims - end of period
|
92 | 109 | 100 | 115 | 134 |
Three
months ended
|
||||||||||||||||||||||
December
31
|
Years
ended September 30
|
|||||||||||||||||||||
(In
millions)
|
2009
|
2008
|
2009
|
2008
|
2007
|
|||||||||||||||||
Asbestos
reserve - beginning of period
|
$ | 543 | $ | 572 | $ | 572 | $ | 610 | $ | 635 | ||||||||||||
Reserve
adjustment
|
- | - | 5 | 2 | 5 | |||||||||||||||||
Amounts
paid
|
(12 | ) | (12 | ) | (34 | ) | (40 | ) | (30 | ) | ||||||||||||
Asbestos
reserve - end of period
|
$ | 531 | $ | 560 | $ | 543 | $ | 572 | $ | 610 |
Three
months ended
|
Year
ended
|
|||||||||||||||
December
31
|
September
30
|
|||||||||||||||
(In
thousands)
|
2009
|
2008
|
(a)
|
2009
|
(a)
|
|||||||||||
Open
claims - beginning of period
|
21
|
27
|
27
|
|||||||||||||
New
claims filed
|
-
|
1
|
1
|
|||||||||||||
Claims
dismissed
|
-
|
(1
|
) |
(7
|
) | |||||||||||
Open
claims - end of period
|
21
|
27
|
21
|
|||||||||||||
Three
months ended
|
Year ended | |||||||||||||||
December
31
|
September
30
|
|||||||||||||||
(In
millions)
|
2009
|
2008
|
(a)
|
2009
|
(a)
|
|||||||||||
Asbestos
reserve - beginning of period
|
$ | 484 | $ | 233 | $ | 233 | ||||||||||
Purchase
accounting reserve adjustment
|
(35 | ) | 105 | 261 | ||||||||||||
Amounts
paid
|
(2 | ) | (3 | ) | (10 | ) | ||||||||||
Asbestos
reserve - end of period
|
$ | 447 | $ | 335 | $ | 484 | ||||||||||
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions)
|
2009
|
2008
|
||||||||
Reserve
- beginning of period
|
$ | 221 | $ | 149 | ||||||
Inherited
Hercules obligations
|
6 | 80 | ||||||||
Disbursements,
net of cost recoveries
|
(7 | ) | (7 | ) | ||||||
Revised
obligation estimates and accretion
|
3 | 2 | ||||||||
Foreign
currency translation
|
(1 | ) | 1 | |||||||
Reserve
- end of period
|
$ | 222 | $ | 225 |
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions - unaudited)
|
2009
|
2008
|
||||||||
SALES
|
||||||||||
Functional
Ingredients
|
$ | 210 | $ | 119 | ||||||
Water
Technologies
|
443 | 318 | ||||||||
Performance
Materials
|
271 | 324 | ||||||||
Consumer
Markets
|
400 | 388 | ||||||||
Distribution
|
729 | 853 | ||||||||
Intersegment sales
(a)
|
(33 | ) | (36 | ) | ||||||
$ | 2,020 | $ | 1,966 | |||||||
OPERATING
INCOME (LOSS)
|
||||||||||
Functional
Ingredients
|
$ | 27 | $ | (7 | ) | |||||
Water
Technologies
|
39 | (6 | ) | |||||||
Performance
Materials
|
8 | 5 | ||||||||
Consumer
Markets
|
67 | 19 | ||||||||
Distribution
|
6 | 10 | ||||||||
Unallocated
and other
|
(1 | ) | (28 | ) | ||||||
$ | 146 | $ | (7 | ) | ||||||
Sales
by Geography
|
2009
|
2008 (a)
|
|||||
North
America
|
65%
|
71%
|
|||||
Europe
|
22%
|
19%
|
|||||
Asia
Pacific
|
8%
|
6%
|
|||||
Latin
America & other
|
5%
|
4%
|
|||||
100%
|
100%
|
||||||
Sales
by Business Segment
|
2009
|
2008 (a)
|
|||||
Functional
Ingredients
|
10%
|
6%
|
|||||
Water
Technologies
|
22%
|
16%
|
|||||
Performance
Materials
|
13%
|
15%
|
|||||
Consumer
Markets
|
19%
|
20%
|
|||||
Distribution
|
36%
|
43%
|
|||||
100%
|
100%
|
||||||
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions)
|
2009
|
2008
|
||||||||
Operating
income (loss)
|
$ | 146 | $ | (7 | ) | |||||
Depreciation and amortization
(a)
|
80 | 72 | ||||||||
EBITDA
|
226 | 65 | ||||||||
Severance
|
- | 26 | ||||||||
Inventory
fair value adjustment
|
- | 21 | ||||||||
Results
of the Hercules business prior to acquisition
|
||||||||||
including
depreciation and amortization
|
- | 35 | ||||||||
Adjusted
EBITDA
|
$ | 226 | $ | 147 | ||||||
(a)
|
Includes,
during the December 2008 quarter, amortization for purchased in-process
research and development of $10
million.
|
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Sales
|
$ | 2,020 | $ | 1,966 | $ | 54 |
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Cost
of sales
|
$ | 1,534 | $ | 1,641 | $ | (107 | ) | |||||||
Gross
profit as a percent of sales
|
24.1 | % | 16.5 | % |
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Selling,
general and administrative expenses
|
$ | 334 | $ | 317 | $ | 17 | ||||||||
As
a % of sales
|
16.5 | % | 16.1 | % |
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Research
and development expenses
|
$ | 20 | $ | 27 | $ | (7 | ) |
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Equity
and other income
|
||||||||||||||
Equity
income
|
$ | 6 | $ | 5 | $ | 1 | ||||||||
Other
income
|
8 | 7 | 1 | |||||||||||
$ | 14 | $ | 12 | $ | 2 |
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Net
gain on divestitures
|
$ | - | $ | 1 | $ | (1 | ) |
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Net
interest and other financing (expense) income
|
||||||||||||||
Interest
expense
|
$ | (41 | ) | $ | (35 | ) | $ | (6 | ) | |||||
Interest
income
|
2 | 8 | (6 | ) | ||||||||||
Other
financing costs
|
(2 | ) | (1 | ) | (1 | ) | ||||||||
$ | (41 | ) | $ | (28 | ) | $ | (13 | ) |
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Other
expenses
|
||||||||||||||
Loss
on currency swaps
|
$ | - | $ | 54 | $ | (54 | ) | |||||||
Loss
on auction rate securities
|
- | 32 | (32 | ) | ||||||||||
$ | - | $ | 86 | $ | (86 | ) |
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Income
tax expense (benefit)
|
$ | 29 | $ | (1 | ) | $ | 30 | |||||||
Effective
tax rate
|
27.6 | % | (0.6 | %) |
(In
millions)
|
2009
|
2008
|
Change
|
|||||||||||
Income
from discontinued operations (net of tax)
|
||||||||||||||
Asbestos-related
litigation reserves and expenses
|
$ | 9 | $ | - | $ | 9 | ||||||||
Loss
on disposal of discontinued operations (net of tax)
|
||||||||||||||
APAC
|
1 | - | 1 | |||||||||||
Total
income (loss) from discontinued operations (net of tax)
|
$ | 10 | $ | - | $ | 10 | ||||||||
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions)
|
2009
|
2008
|
||||||||
Operating
information
|
||||||||||
Functional Ingredients (a)
(b)
|
||||||||||
Sales
per shipping day
|
$ | 3.4 | $ | 4.0 | ||||||
Metric
tons sold (thousands)
|
37.4 | 24.4 | ||||||||
Gross
profit as a percent of sales
|
33.7 | % | 15.7 | % | ||||||
Water Technologies (a)
(b)
|
||||||||||
Sales
per shipping day
|
$ | 7.2 | $ | 5.1 | ||||||
Gross
profit as a percent of sales
|
36.6 | % | 30.3 | % | ||||||
Performance Materials
(a)
|
||||||||||
Sales
per shipping day
|
$ | 4.4 | $ | 5.2 | ||||||
Pounds
sold per shipping day
|
4.0 | 4.3 | ||||||||
Gross
profit as a percent of sales
|
18.4 | % | 15.9 | % | ||||||
Consumer Markets
(a)
|
||||||||||
Lubricant
sales (gallons)
|
40.3 | 33.0 | ||||||||
Premium
lubricants (percent of U.S. branded volumes)
|
28.3 | % | 27.1 | % | ||||||
Gross
profit as a percent of sales
|
33.9 | % | 21.8 | % | ||||||
Distribution
(a)
|
||||||||||
Sales
per shipping day
|
$ | 11.8 | $ | 13.8 | ||||||
Pounds
sold per shipping day
|
14.3 | 15.5 | ||||||||
Gross
profit as a percent of sales
|
9.2 | % | 8.6 | % | ||||||
(a)
|
Sales
are defined as net sales. Gross profit as a percent of sales is
defined as sales, less cost of sales divided by
sales.
|
(b)
|
Industry
segment results from November 14, 2008 forward include operations acquired
from Hercules Incorporated.
|
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions)
|
2009
|
2008
|
||||||||
Sales
|
||||||||||
Functional
Ingredients
|
$ | 210 | $ | 119 | ||||||
Water
Technologies
|
443 | 318 | ||||||||
Performance
Materials
|
271 | 324 | ||||||||
Consumer
Markets
|
400 | 388 | ||||||||
Distribution
|
729 | 853 | ||||||||
Intersegment
sales
|
(33 | ) | (36 | ) | ||||||
$ | 2,020 | $ | 1,966 | |||||||
Operating
income (loss)
|
||||||||||
Functional
Ingredients
|
$ | 27 | $ | (7 | ) | |||||
Water
Technologies
|
39 | (6 | ) | |||||||
Performance
Materials
|
8 | 5 | ||||||||
Consumer
Markets
|
67 | 19 | ||||||||
Distribution
|
6 | 10 | ||||||||
Unallocated
and other
|
(1 | ) | (28 | ) | ||||||
$ | 146 | $ | (7 | ) | ||||||
Depreciation
and amortization
|
||||||||||
Functional Ingredients
(a)
|
$ | 27 | $ | 21 | ||||||
Water Technologies
(a)
|
24 | 21 | ||||||||
Performance
Materials
|
13 | 13 | ||||||||
Consumer
Markets
|
9 | 9 | ||||||||
Distribution
|
7 | 8 | ||||||||
$ | 80 | $ | 72 | |||||||
(a)
|
Includes,
during the December 2008 quarter, amortization for purchased in-process
research and development of $5 million within both Functional Ingredients
and Water Technologies.
|
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions)
|
2009
|
2008
|
||||||||
Operating
income (loss)
|
$ | 27 | $ | (7 | ) | |||||
Depreciation and amortization
(a)
|
27 | 21 | ||||||||
EBITDA
|
54 | 14 | ||||||||
Inventory
fair value adjustment
|
- | 14 | ||||||||
Results
of the Hercules business prior to acquisition
|
||||||||||
including
depreciation and amortization
|
- | 21 | ||||||||
Adjusted
EBITDA
|
$ | 54 | $ | 49 | ||||||
(a)
|
Includes
$5 million for purchased in-process research and development expensed
during the prior year
period.
|
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions)
|
2009
|
2008
|
||||||||
Operating
income (loss)
|
$ | 39 | $ | (6 | ) | |||||
Depreciation and amortization
(a)
|
24 | 21 | ||||||||
EBITDA
|
63 | 15 | ||||||||
Severance
|
- | 2 | ||||||||
Inventory
fair value adjustment
|
- | 7 | ||||||||
Results
of the Hercules business prior to acquisition
|
||||||||||
including
depreciation and amortization
|
- | 10 | ||||||||
Adjusted
EBITDA
|
$ | 63 | $ | 34 | ||||||
(a)
|
Includes
$5 million for purchased in-process research and development expensed
during the prior year period.
|
(In
millions)
|
2009
|
2008
|
||||||||
Cash
(used) provided by:
|
||||||||||
Operating
activities from continuing operations
|
$ | 35 | $ | 74 | ||||||
Investing
activities from continuing operations
|
26 | (2,188 | ) | |||||||
Financing
activities from continuing operations
|
(24 | ) | 1,460 | |||||||
Discontinued
operations
|
13 | 5 | ||||||||
Effect
of currency exchange rate changes on cash and cash
equivalents
|
4 | (15 | ) | |||||||
Net
increase (decrease) in cash and cash equivalents
|
$ | 54 | $ | (664 | ) |
Three
months ended
|
||||||||||
December
31
|
||||||||||
(In
millions)
|
2009
|
2008
|
||||||||
Cash
flows provided by operating activities from continuing
operations
|
$ | 35 | $ | 74 | ||||||
Less:
|
||||||||||
Additions
to property, plant and equipment
|
(21 | ) | (38 | ) | ||||||
Cash
dividends paid
|
(6 | ) | (6 | ) | ||||||
Free
cash flows
|
$ | 8 | $ | 30 |
December
31
|
September
30
|
December
31
|
||||||||||||
(In
millions)
|
2009
|
2009
|
2008
|
|||||||||||
Short-term
debt
|
$ | 28 | $ | 23 | $ | 246 | ||||||||
Long-term
debt (including current portion)
|
1,566 | 1,590 | 2,222 | |||||||||||
Total
debt
|
$ | 1,594 | $ | 1,613 | $ | 2,468 | ||||||||
Cash
and cash equivalents
|
$ | 406 | $ | 352 | $ | 222 | ||||||||
Auction
rate securities
|
$ | 126 | $ | 170 | $ | 225 |
|
(a)
|
As
of the end of the period covered by this quarterly report, Ashland, under
the supervision and with the participation of its management, including
Ashland’s Chief Executive Officer and its Chief Financial Officer,
evaluated the effectiveness of Ashland’s disclosure controls and
procedures pursuant to Rule 13a-15(b) and 15d-15(b) promulgated under the
Securities Exchange Act of 1934, as amended. Based upon that
evaluation, the Chief Executive Officer and Chief Financial Officer have
concluded that the disclosure controls and procedures were
effective.
|
|
(b)
|
During the three months ended December 31, 2009,
there were no significant changes in Ashland’s internal control
over financial reporting, or in other factors, that occurred during the
period covered by this quarterly report that have materially affected, or
are reasonably likely to materially affect, Ashland’s internal control
over financial reporting.
|
1)
|
Mark
C. Rohr, Theodore M. Solso and Michael J. Ward were elected as Class III
directors to a three-year term with the vote totals referenced
below.
|
Votes
|
|||||
For
|
Against
|
Abstain
|
|||
Mark
C. Rohr
|
54,049,645
|
4,115,473
|
2,217,973
|
||
Theodore
M. Solso
|
53,383,848
|
4,791,292
|
2,207,951
|
||
Michael
J. Ward
|
54,614,611
|
3,557,270
|
2,211,210
|
2)
|
The
appointment of PricewaterhouseCoopers LLP as independent registered public
accountants for fiscal year ending September 30, 2010, was ratified by a
vote of 68,879,404 shares voting for, 571,125 shares voting against, and
204,998 shares abstaining.
|
|
(a)
|
Exhibits
|
|
12
|
Computation
of Ratio of Earnings to Fixed
Charges.
|
|
31.1
|
Certificate
of James J. O’Brien, Chief Executive Officer of Ashland pursuant to
Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
31.2
|
Certificate
of Lamar M. Chambers, Chief Financial Officer of Ashland pursuant to
Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
32
|
Certificate
of James J. O’Brien, Chief Executive Officer of Ashland, and Lamar M.
Chambers, Chief Financial Officer of Ashland pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
|
Ashland Inc. | ||||
(Registrant) | ||||
February
5, 2010
|
/s/
Lamar M. Chambers
|
|||
|
Lamar
M. Chambers
|
|||
|
Senior
Vice President and Chief Financial Officer
(on behalf of the
Registrant and as principal
financial
officer)
|
Exhibit
|
|
No.
|
Description
|
|
12
|
Computation
of Ratio of Earnings to Fixed
Charges.
|
|
31.1
|
Certificate
of James J. O’Brien, Chief Executive Officer of Ashland pursuant to
Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
31.2
|
Certificate
of Lamar M. Chambers, Chief Financial Officer of Ashland pursuant to
Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
32
|
Certificate
of James J. O’Brien, Chief Executive Officer of Ashland, and Lamar M.
Chambers, Chief Financial Officer of Ashland pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
|